deletions | additions       diff --git a/section_Drug_resistance_Global_and__.tex b/section_Drug_resistance_Global_and__.tex  index 38537b9..cb14244 100644  --- a/section_Drug_resistance_Global_and__.tex  +++ b/section_Drug_resistance_Global_and__.tex 
...
\subsection{Resistance to second-line drugs among patients with MDR-TB}  Data from 75 73  countries and 5 territories  were used to produce global estimates of the following proportions: (i) patients with MDR-TB who had XDR-TB; (ii) patients with MDR-TB who had fluoroquinolone resistance; (iii) patients with MDR-TB who had resistance to second-line injectable drugs and fluoroquinolones but not XDR-TB. The latest available national and subnational data from each country were analysed using logistic regression models with robust standard errors to account for the clustering effect at the level of the country or territory. The analysis was limited to countries in which more than 66\% of MDR-TB cases received second-line DST.